What is the ticker symbol for Apexigen?

Apexigen trades under the ticker APGN on NASDAQ.

What sector does Apexigen operate in?

Apexigen is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze APGN in a portfolio?

PortView shows APGN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Apexigen (APGN) Stock Analysis

NASDAQHealthcareBiotechnology

$0.39+8.48%

1-year price historyRange $0.34 – $7.77

52-week range$0.39

$0.33$8.28

Track APGN in your portfolio for free · Portfolio tracker

What Apexigen does

Apexigen Inc., established in 2010 and based in San Carlos, California, is a clinical-stage biotechnology company dedicated to the discovery and advancement of antibody-based therapies for oncological diseases. The company's developmental pipeline features several promising candidates. A primary focus is APX005M, a humanized agonist antibody currently in Phase II clinical trials. This therapeutic agent is being explored for its efficacy against a variety of solid tumors, including melanoma, esophageal and gastroesophageal junction cancers, sarcoma, and rectal and ovarian malignancies, often in conjunction with other established treatments like immunotherapy, chemotherapy, radiation therapy, and cancer vaccines. Additionally, Apexigen is progressing APX601, a humanized antagonist antibody, through Phase I/II clinical trials for numerous tumor indications. Rounding out their experimental portfolio is APX801, an NK cell engager engineered to stimulate natural killer cells to eradicate cancerous cells.

Key metrics

Market cap

$9.57M

P/E (TTM)

-0.23

EPS (TTM)

$-1.71

Beta

3.62

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$0.43

200-day avg

$0.92

52-week high

$8.28

52-week low

$0.33

CEO

Xiaodong Yang

ETFs linked to APGN

Broad-market and Healthcare sector ETFs an investor holding Apexigen is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how APGN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze APGN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Apexigen?: Apexigen trades under the ticker APGN on NASDAQ.
Which exchange is APGN listed on?: APGN is listed on NASDAQ.
What sector does Apexigen operate in?: Apexigen is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze APGN in a portfolio?: PortView shows APGN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.